pharma · Clostridium Difficile Infection · Ulcerative Colitis · MCRB
Seres Therapeutics
Seres Therapeutics trial registry — 8 ClinicalTrials.gov studies with program phase, status, and indication context.
Cambridge, USA HQ
2010 Founded
129 Employees
Public company Type
MCRB · NYSE Ticker
Company details
- Status
- Public
- HQ
- Cambridge, USA
- Founded
- 2010
- Employees
- 129
- Programs
- 8
- Drugs
- 7
- Patents
- 36
Seres Therapeutics clinical trials
Registry index of 8 ClinicalTrials.gov studies linked to Seres Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.
Seres Therapeutics trial registry — 8 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Seres Therapeutics.
-
Vancomycin Pre-Treatment — Phase 2
Clinical update -
Vancomycin Pre-Treatment — Phase 1
Clinical update -
SER-262 — Phase 1
Clinical update -
SER-109 — Phase 3
Clinical update -
SER-109 — Phase 2
Clinical update -
Placebo for antibiotic — Phase 1
Clinical update -
SER-109 — Phase 3
Clinical update -
SER-287 — Phase 1
Clinical update